Zobrazeno 1 - 10 of 598 pro vyhledávání: '"F Großmann"'
1
Akademický článek
Prevention of psychosocial distress consequences in somatic hospital inpatients via a stepped and collaborative care model: protocol of SomPsyNet, a stepped wedge cluster randomised trial
Autor: Günther Fink, Matthias Schwenkglenks, Kaspar Wyss, M Weber, Rainer Schaefert, S Fuchs, G Fink, S Werner, R Baumgartner, J Beck, M Hotopf, M Bachmann, C Huber, S Trost, S Bassetti, Sibil Tschudin, M Schwenkglenks, K Wyss, A Frick, A Studer, N Schur, A Hermann, S Bosman, Gunther Meinlschmidt, Seraina Caviezel, Alexander Frick, Iris Baenteli, Christina Karpf, Anja Studer, Marco Bachmann, Andreas Dörner, Sarah Trost, Tabea Rocco, NJ Aebi, S Caviezel, I Baenteli, S Bahmané, G Bales, K Bally, D Buechel, S Dietsche, A Dörner, C Eberle, L Ebner, J Erb, P Ettlin, L Flückiger, F Grossmann, L Isler-Christ, C Karpf, MC Katapodi, RC Keller, S Klimmeck, UE Lang, Y Liechti, S Mazander, G Meinlschmidt, A Minzer, V Ochs, R Schaefert, F Schiess, F Schirmer, P Schwob, SF Seelmann, T Steffen, F Stiefel, M Tegethoff, S Tschudin, C Urech, T von Allmen, A Wetz, D Weyermann, V Yarkova, C Zäh, L Zarifoglu
Publikováno v: BMJ Open, Vol 13, Iss 11 (2023)
Introduction Approximately 30% of somatic hospital inpatients experience psychosocial distress, contributing to increased (re-)hospitalisation rates, treatment resistance, morbidity, and direct and indirect costs. However, such distress often remains
Externí odkaz: https://doaj.org/article/b7ab45a49fd543508e3a7880018e50fc
Zobrazit plný text záznamu
2
Akademický článek
Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
Autor: Justin C. Moser, Danli Chen, Siwen Hu‐Lieskovan, Kenneth F. Grossmann, Shiven Patel, Sarah V. Colonna, Jian Ying, John R. Hyngstrom
Publikováno v: Cancer Medicine, Vol 8, Iss 18, Pp 7637-7643 (2019)
Abstract Background The optimal treatment sequence for patients with advanced BRAF V600 mutant melanoma is unknown. BRAF/MEK inhibition (BRAF/MEKi), single agent anti‐PD‐1 (aPD‐1) antibodies and combination immune checkpoint inhibition with niv
Externí odkaz: https://doaj.org/article/52b6fa49a3e44388aa94c0a04848fd13
Zobrazit plný text záznamu
3
Akademický článek
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Autor: Ramses Sadek, Mohammed Milhem, Olivier Rixe, David Munn, Christopher M Smith, Yousef Zakharia, Joseph Drabick, Kenneth F Grossmann, Robert R McWilliams, Montaser F Shaheen, Ravindra Kolhe, Rafal Pacholczyk, Lucinda L Tennant, Eugene P Kennedy, Charles J Link Jr, Nicholas N Vahanian, Jiayi Yu, Steven S Shen, Erik L Brincks, Gabriela R Rossi
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background The indoleamine 2,3-dioxygenase (IDO) pathway is a key counter-regulatory mechanism that, in cancer, is exploited by tumors to evade antitumor immunity. Indoximod is a small-molecule IDO pathway inhibitor that reverses the immunosuppressiv
Externí odkaz: https://doaj.org/article/3e3e02066379461ebd661d3bcc62f60a
Zobrazit plný text záznamu
6
Akademický článek
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy
Autor: Mariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, Lee D Cranmer, Clara Curiel-Lewandrowski, Vernon K Sondak, Clara E Stemwedel, Susan M Swetter, John Vetto, Tawnya Bowles, Robert P Dellavalle, Larisa J Geskin, Douglas Grossman, Kenneth F Grossmann, Jason E Hawkes, Joanne M Jeter, Caroline C Kim, John M Kirkwood, Aaron R Mangold, Frank Meyskens, Michael E Ming, Kelly C Nelson, Michael Piepkorn, Brian P Pollack, June K Robinson, Arthur J Sober, Shannon Trotter, Suraj S Venna, Sanjiv Agarwala, Rhoda Alani, Bruce Averbook, Anna Bar, Mirna Becevic, Neil Box, William E Carson, Pamela B Cassidy, Suephy C Chen, Emily Y Chu, Darrel L Ellis, Laura K Ferris, David E Fisher, Kari Kendra, David H Lawson, Philip D Leming, Kim A Margolin, Svetomir Markovic, Mary C Martini, Debbie Miller, Debjani Sahni, William H Sharfman, Jennifer Stein, Alexander J Stratigos, Ahmad Tarhini, Matthew H Taylor, Oliver J Wisco, Michael K Wong
Publikováno v: Melanoma Management, Vol 4, Iss 1, Pp 13-37 (2017)
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is responsible for the majority of skin cancer-related deaths. Currently, there is no national
Externí odkaz: https://doaj.org/article/8e14d4bd2ae34bdfbf467c03771d28b3
Zobrazit plný text záznamu
7
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review
Autor: Islam Eljilany, Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood, Vernon K. Sondak, Antoni Ribas, Kenneth F. Grossmann, Ahmad A. Tarhini
Publikováno v: Cancers; Volume 15; Issue 9; Pages: 2561
Cancers, vol 15, iss 9
Background: Treatment with immune checkpoint inhibitors (ICIs) has been linked to granulomatous and sarcoid-like lesions (GSLs) affecting different organs. This study sought to evaluate GSL incidence in patients with high-risk melanoma treated with c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a030e012507c20ce5535d29f2bdc4609
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje